Aug 17, 2018
Kelsey Moody — Antibody Mimetic for Parkinson’s Disease | LEAF
Posted by Steve Hill in categories: biotech/medical, life extension
Kelsey Moody, CEO of Ichor Therapeutics, discusses the creation of a gut-stable antibody mimetic for Parkinson’s disease and announces 10 million dollars in investment from Juvenescence into Ichor portfolio company Antoxerene Inc. at the Ending Age-Related Diseases conference in NYC.
More at: https://www.leafscience.org/ending-age-related-diseases-2018/